Researcher Discovers Role of Gene Variant Associated With Alzheimer's Disease - HealthCanal.com
Researcher Discovers Role of Gene Variant Associated With Alzheimer's Disease HealthCanal.com By Leslie Ridgeway - A gene variant responsible for vascular damage to the brain is a promising new target for drug therapy to fight Alzheimer's disease and other neurodegenerative diseases, according to research published on May 16 in Nature.
Athersys Reports First Quarter 2012 Results - MarketWatch (press release)
Athersys Reports First Quarter 2012 Results MarketWatch (press release) Raised $9.0 million in March 2012 through a private placement of common stock and warrants; -- Met with FDA to discuss advancing clinical development of MultiStem(R) for the prevention of graft-versus-host disease (GvHD), on basis of positive results ...
Amicus Therapeutics Announces First Quarter 2012 Financial Results MarketWatch (press release) Final enrollment on track by YE12 -- Current enrollment in Phase 2 Study 013 for Fabry disease includes patients in higher dose group of migalastat HCl (450 mg) co-administered with Fabrazyme and in lower dose group of migalastat HCl (150 mg) ...
BetterWayHealth.com Explores the Amazing Omega 3's! - Staugnews
BetterWayHealth.com Explores the Amazing Omega 3's! Staugnews Some evidence even suggests that people with certain circulatory problems, such as varicose veins, benefit from Omega-3's, which may stimulate blood circulation and even reduce blood pressure. Just think! A product that may actually reduce the risk of ...
Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... - EON: Enhanced Online News (press release)
Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... EON: Enhanced Online News (press release) ... the treatment of cardiac rhythm disorders. With 3750 employees worldwide, the Group focuses on three major therapeutic areas that include: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, ...
Do You Have Tapeworms In Your Brain? Maybe. - Jezebel
Do You Have Tapeworms In Your Brain? Maybe. Jezebel Neurocysticercosis, as this disease is called, can also block the flow of cerebrospinal fluid, which puts pressure on the brain and can cause a coma or even death. The parasite can also cause seizures and violent convulsions of your muscles.
Costs of screening children for sudden cardiac death outweigh its benefits - EurekAlert (press release)
Costs of screening children for sudden cardiac death outweigh its benefits EurekAlert (press release) Boston, MA? An article, published in Circulation by Laurel K. Leslie, MD, MPH from the Tufts Clinical and Translational Science Institute (CTSI) and colleagues from Tufts Medical Center and Floating Hospital for Children at Tufts Medical Center, ...
Health calendar Montgomery Advertiser Whether the wounds are the result of pressure, problems with circulation, or diseases such as diabetes, new treatments are available. Call 293-8138 for an appointment or for more information. Senior Advantage. Addressing the needs and concerns of ...
Why Alzheimer's disease scares us? (Part 3) - Arab News
Why Alzheimer's disease scares us? (Part 3) Arab News COM I would like to return to our subject of Alzheimer disease where I left it three weeks ago on April 11. The condition is a cause of concern to many of us as we see first hand how it has escalated in the last several decades, ...
Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... - MarketWatch (press release)
Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... MarketWatch (press release) ... the treatment of cardiac rhythm disorders. With 3750 employees worldwide, the Group focuses on three major therapeutic areas that include: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, ...
What our clients and candidates are saying about us: I intend to...keep a watch on your excellent website; I am glad you "found" me and vice-versa! Thanks for your interest. - Ken
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.